This page collects WhisperX intelligence signals tagged #Drug Safety. It is designed for humans, search engines, and AI agents: each item links to a canonical source-backed record with sector, source, timestamp, credibility, and exportable structured data.
The U.S. Food and Drug Administration is preparing to reverse a significant safety policy, moving to potentially allow compounding pharmacies to produce more than a dozen injectable peptides it had previously banned. These substances, removed from the approved compounding list in 2023, were flagged for 'potentially sig...
The U.S. Food and Drug Administration has formally requested additional safety data from Eli Lilly concerning potential liver injury linked to its recently approved obesity pill. This regulatory scrutiny, detailed in an April 1 letter posted on the agency's website, signals ongoing safety concerns that could impact the...